BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32558231)

  • 1. Dermatofibrosarcoma protuberans in children and adolescents: The European Paediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).
    Brennan B; Zanetti I; De Salvo GL; Orbach D; Gallego S; Francotte N; Schifflers S; Van Noesel M; Kelsey A; Casanova M; Dagrada GP; Collini P; Zin A; Santoro L; Ferrari A
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28351. PubMed ID: 32558231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005).
    Brennan B; Zanetti I; Orbach D; Gallego S; Francotte N; Van Noesel M; Kelsey A; Casanova M; De Salvo GL; Bisogno G; Ferrari A
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
    Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
    Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; Brennan B; Casanova M; Corradini N; Berlanga P; Schoot RA; Ramirez-Villar GL; Safwat A; Guillen Burrieza G; Dall'Igna P; Alaggio R; Lyngsie Hjalgrim L; Gatz SA; Orbach D; van Noesel MM
    Cancer Manag Res; 2022; 14():2885-2902. PubMed ID: 36176694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
    Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
    Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control.
    Harati K; Lange K; Goertz O; Lahmer A; Kapalschinski N; Stricker I; Lehnhardt M; Daigeler A
    World J Surg Oncol; 2017 Jan; 15(1):5. PubMed ID: 28056985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated?
    Huis In 't Veld EA; van Coevorden F; Grünhagen DJ; Smith MJ; van Akkooi ACJ; Wouters MWJM; Hayes AJ; Verhoef C; Strauss DC; van Houdt WJ
    Cancer; 2019 Mar; 125(5):735-741. PubMed ID: 30644528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital dermatofibrosarcoma protuberans: 30 years of follow-up.
    von Stebut E; Brsuninger W
    J Dtsch Dermatol Ges; 2007 Mar; 5(3):223-5. PubMed ID: 17338798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatofibrosarcoma protuberans: our 10-year experience on 80 patients.
    Zhou X; Sun D; Liu Y; Sun Q; Yuan Z; Luo X; Yang J; Chen J
    J Dermatolog Treat; 2020 Sep; 31(6):554-558. PubMed ID: 31116621
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome After Surgical Treatment of Dermatofibrosarcoma Protuberans (DFSP): Does it Require Extensive Follow-up and What is an Adequate Resection Margin?
    Alshaygy I; Mattei JC; Basile G; Griffin AM; Gladdy RA; Swallow CJ; Dickson BC; Wunder JS; Ferguson PC
    Ann Surg Oncol; 2023 May; 30(5):3106-3113. PubMed ID: 36658251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
    Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
    Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread.
    Ratner D; Thomas CO; Johnson TM; Sondak VK; Hamilton TA; Nelson BR; Swanson NA; Garcia C; Clark RE; Grande DJ
    J Am Acad Dermatol; 1997 Oct; 37(4):600-13. PubMed ID: 9344201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatofibrosarcoma Protuberans: Wide Local Excision Versus Mohs Micrographic Surgery.
    Mullen JT
    Surg Oncol Clin N Am; 2016 Oct; 25(4):827-39. PubMed ID: 27591501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative Re-excision is a Safe and Simple Alternative to Radical Resection in Revision Surgery for Dermatofibrosarcoma Protuberans.
    Snow H; Davies E; Strauss DC; Smith M; Hayes AJ
    Ann Surg Oncol; 2020 Mar; 27(3):919-923. PubMed ID: 31664620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans.
    Gloster HM; Harris KR; Roenigk RK
    J Am Acad Dermatol; 1996 Jul; 35(1):82-7. PubMed ID: 8682970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.
    Monnier D; Vidal C; Martin L; Danzon A; Pelletier F; Puzenat E; Algros MP; Blanc D; Laurent R; Humbert PH; Aubin F
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1237-42. PubMed ID: 17062038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of surgical treatment for dermatofibrosarcoma protuberans according to width of gross resection margin.
    Woo KJ; Bang SI; Mun GH; Oh KS; Pyon JK; Lim SY
    J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):395-401. PubMed ID: 26646402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial infiltration by recurrent scalp dermatofibrosarcoma protuberans.
    Abe T; Kamida T; Goda M; Inoue R; Fujiki M; Kobayashi H; Hatano Y; Shibuya H; Fujiwara S; Terashi H; Mori T
    J Clin Neurosci; 2009 Oct; 16(10):1358-60. PubMed ID: 19560926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.